Visceral leishmaniasis: Clinical and laboratorial aspects;Leishmaniose visceral: Aspectos clínicos e laboratoriais

Jornal de Pediatria

Volumn 78, Issue 2, 2002, Pages 120-127

  Pastorino, Antonio C ^a,c   Jacob, Cristina M A ^a,b   Oselka, Gabriel W ^a   Carneiro Sampaio, Magda M S ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Faculdade de Medicina da USP SP

^c Faculdade de Medicina da USP SP ^*  (Brazil)

Author keywords

Diagnosis; Infancy; Kala Azar; Treatment; Visceral leishmaniasis

Indexed keywords

EID: 54149114410     PISSN: 00217557     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0021-75572002000200010     Document Type: Article

References (29)

1. Lainson R, Shaw JJ. Evolution, classification and geographical distribution. In: Lainson R, Shaw JJ, eds. The leishmaniasis. London: Academic Press; 1987. p.1-120.
2. Ashford RW, Desjeux P, Raadt P. Estimation of population at risk of infection and number of cases leishmaniasis. Parasitol Today 1992;8:104-5.
3. World Health Organization. The Leishmaniasis. Geneva; 1984. (OMS Tech Rep Ser, n.701).
4. Ministério da Saúde. Fundação Nacional de Saúde. Boletim Epidemiológico. Evolução temporal das doenças de notificação compulsória no Brasil de 1980 a 1998. Ano III. 1999; p.50.
5. Carvalho EM, Badaró R, Reed SG, Jones TC, Johnson JR WD. Absence of gamma interferon and interleukin 2 production during active visceral leishmaniasis. J Clin Invest 1985;76:2066-9.
6. Sadick, MD, Locksley, RM, Tubbs, C, Raff HV. Murine cutaneous leishmaniasis: resistance correlates with the capacity to generate interferon-gamma in response to Leishmania antigens in vitro. J Immunol 1987;136:655-61.
7. Alencar JE, Aragão TC. Leishmaniose visceral no Ceará. Sintomas observados em 174 casos. Publicações Médicas 1955;28:197.
8. Badaró R, Jones JC, Carvalho EM, Sampaio D, Reed SG, Barral A, et al. New perspectives on a subclinical form of visceral leishmaniasis. J Infect Dis 1986; 154:1003-11.
9. Kar K. Serodiagnosis of leishmaniasis. Crit Rev Microbiol 1995;21:123-52.
10. Nuzum E, White III F, Dietze R, Wages J, Grogl M, Berman J. Diagnosis of symptomatic visceral leishmaniasis by use of the polymerase chain reaction on patient blood. J Infect Dis 1995;171:751-4.
11. Ravel S, Cuny G, Reynes J, Veas F. A highly sensitive and rapid procedure for direct PCR detection of Leishmania infantum within human peripheral blood mononuclear cells. Acta Trop 1995;59:187-96.
12. Berman JD. Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years. Clin Infect Dis 1997;24:684-703.
13. Fujimura MD. Níveis séricos das subclasses de imunoglobulina G em crianças normais e nefróticas [tese]. São Paulo: Faculdade de Medicina, Universidade de São Paulo; 1990.
14. Chang KP, Hendricks LD. Laboratory cultivation and maintenance of Leishmania. In: Chang KP, Bray RS, eds. Leishmaniasis. 3rd ed. New York: Elsevier Science; 1985. p.214-42.
15. Ho EA, Soong TH, Li Y. Comparative merits of sternum, spleen and liver punctures in the study of human visceral leishmaniasis. Trans R Soc Trop Med Hyg 1948; 41:629-36.
16. Chulay JD, Bryceson ADM. Quantitation of amastigotes of Leishmania donovani in smears of splenic aspirates from patients with visceral leishmaniasis. Am J Trop Med Hyg 1983;32:475-9.
17. Minodier P, Garnier JM. Childhood visceral leishmaniasis in Provence. Arch Pediatr 2000; 7 Suppl 3:572-7.
18. Maltezou HC, Siafas C, Mavrikou M, Spyridis P, Stavrinadis C, Karpathios T, et al. Visceral leishmaniasis during childhood in southern Greece. Clin Infect Dis 2000; 31:1139-43.
19. Harrison LH, Naidu TG, Drew JS, Alencar JE, Pearson RD. Reciprocal relationship between undernutrition and the parasitic disease visceral leishmaniasis. Rev Infect Dis 1986;8:447-53.
20. Pastorino AC, Jacob CMA, Porta G, Petlik MI, Oselka GW, Miura IK, et al. Leishmaniose visceral. Diagnóstico pela imunoperoxidase em tecido hepático. Anais das Jornadas Latino Americanas de Hepatologia; 1988; Medelin (Colômbia).
21. Teixeira R. Experiências vividas com a leishmaniose visceral. 1954-1980. Aspectos epidemiológicos, sorológicos e evolutivos [tese]. Salvador: Faculdade de Medicina, Universidade Federal da Bahia; 1980.
22. El Amin EM, Wright EP, Vlug A. Characterization of the humoral immune response in Sudanese leishmaniasis: specific antibody detected by class- and subclass-specific reagents. Clin Exp Immunol 1986;64:14-9.
23. Zwingenberger K, Harms G, Pedrosa C, OmenaS, SandkampB, Neifer S. Determinants of the immune response in visceral leishmaniasis: evidence for predominance of endogenous interleukin 4 over interferon-gamma production. Clin Immunol Immunopathol 1990;57:242-9.
24. Andrade TM, Carvalho EM, Rocha H. Bacterial infections in patients with visceral leishmaniasis. J Infect Dis 1990;162:1354-9.
25. Nicodemo EL. Infecção secundária no curso da leishmaniose visceral [dissertação]. São Paulo: Faculdade de Medicina, Universidade de São Paulo; 1991.
26. Lee MB, Gilbert HM. Current approaches to leishmaniasis. Infect Med 1999;16:34-45.
27. Badaró R, Falcoff E, Badaró FS, Carvalho EM, Sampaio DP, Barral A, et al. Treatment of visceral leishmaniasis with pentavalent antimony and interferon gamma. N Engl J Med 1990;322: 16-21.
28. Khalil EA, El Hassan AM, Zijlstra EE, Mukhtar MM, Ghalib HW, Musa B, et al. Autoclaved Leishmania major vaccine for prevention of visceral leishmaniasis: a randomized, double-blind, BCG-controlled trial in Sudan. Lancet 2000;356:1565-9.
29. Sundar S, Makharia A, More DK, Agrawal G, Voss A, Fischer C, et al. Short-course oral miltefosine for treatment of visceral leishmaniasis. Clin Infect Dis 2000; 31:1110-3.